41371-14-6 Usage
Uses
Used in Pharmaceutical Industry:
Cholesterol N-butyl carbonate is utilized as an ingredient in drug formulations, particularly for the development of lipid-based drug delivery systems. Its ability to improve the solubility and bioavailability of certain drugs makes it a valuable component in the creation of new therapeutic agents.
Used in Drug Delivery Systems:
Cholesterol N-butyl carbonate is employed as a key component in the development of novel drug delivery systems. Its enhanced solubility in organic solvents allows for better drug encapsulation and targeted delivery, which can improve the efficacy and safety of various medications.
Used in Biomaterials Development:
Cholesterol N-butyl carbonate may have potential applications in the development of innovative biomaterials for drug delivery and tissue engineering. Its unique properties can contribute to the design of advanced materials that facilitate efficient drug administration and promote tissue regeneration or repair.
Check Digit Verification of cas no
The CAS Registry Mumber 41371-14-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,1,3,7 and 1 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 41371-14:
(7*4)+(6*1)+(5*3)+(4*7)+(3*1)+(2*1)+(1*4)=86
86 % 10 = 6
So 41371-14-6 is a valid CAS Registry Number.
InChI:InChI=1/C32H54O3/c1-7-8-20-34-30(33)35-25-16-18-31(5)24(21-25)12-13-26-28-15-14-27(23(4)11-9-10-22(2)3)32(28,6)19-17-29(26)31/h12,22-23,25-29H,7-11,13-21H2,1-6H3/t23-,25+,26+,27-,28+,29+,31+,32-/m1/s1
41371-14-6Relevant articles and documents
Cycling of waste fusel alcohols from sugar cane industries using supercritical carbon dioxide
Pereira,Pereira,Crédito,Gir?o,Idehara,González
, p. 81515 - 81522 (2015)
The present study describes the clean synthesis of non-phosgene organic carbonates (NPOCs) from a selective multicomponent reaction with two important by-products from sugar and alcohol industries, namely, fusel alcohols and carbon dioxide, in the presence of 1,8-diazabicycloundecene (DBU), 1,5-diazabicyclo[4.3.0]-non-5-ene (DBN) or 1,3,4,6,7,8-hexahydro-2H-pyrimido[1,2-a]-pyrimidine (TBD) and an alkylating agent. The bases were used for the nucleophilic activation of the alcohols. The synthesis of carbonates was carried out without solvent and confirmed by GC-MS with EI ionization mode, 1H- and 13C-NMR and FT-IR analysis. The carbonates were obtained in excellent yields. Crude fusel alcohol can be converted to alkylcarbonates. The proposed methodology can also be employed to convert other hydroxylated compounds into carbonates.
